IR@PKUHSC  > 北京大学第一临床医学院  > 感染疾病科
其他题名The prediction and validation of liver fibrosis by a noninvasive model and validation in patients with chronic hepatitis B
刘卫平1; 许德军1; 赵连荣1; 陆忠华1; 王玉华1; 郎振为1; 王贵强1
关键词肝纤维化 肝炎 诊断 乙型 预测模型 慢性 Liver Fibrosis Hepatitis b Diagnosis Chronic Predictive Model
收录类别中国科技核心期刊 ; 中文核心期刊 ; CSCD
文章类型Journal Article
摘要目的 建立慢性乙型肝炎肝纤维化的无创检测模型,并对其应用价值进行验证.方法 慢性乙型肝炎190例,模型组(110例)以肝组织学分期为标准,建立纤维化预测模型,在验证组(80例)评价其应用价值.结果 该研究共纳入20项指标,在模型组经过logistic分析,建立了结合珠蛋白、γ-谷氨酰转肽酶和血小板计数3项指标构成的模型(FibroScore).FibroScore判别显著纤维化(S≥2)、严重纤维化(S≥3)、肝硬化(S=4)和任何程度纤维化(S≥1)的曲线下面积(AUC)分别为0.835、0.820、0.843、0.832,准确率分别为75.5%、69.1%、78.2%和75.0%.验证组与模型组的AUC差异无统计学意义.FibroScore对HBeAg阳性或阴性慢性乙型肝炎肝纤维化均具有较高的诊断价值(AUC为0.755~0.857).以0.18作为除外显著纤维化的界值,阴性预测值为90.0%;以0.70作为诊断显著纤维化的界值,阳性预测值为82.7%.如果对<0.18和≥0.70的病例不行肝活检,可减少58.4%(111/190)的肝活检,准确率为84.7%(94/111).结论 FibroScore可较准确预测慢性乙型肝炎病人是否存在显著纤维化,而且对HBeAg阳性或阴性慢性乙型肝炎均具有较高的应用价值. Objective To develop a simple model for the noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis B and to testify its diagnostic value. Methods One hundred and ninety patients with chronic hepatitis B who had undergone liver biopsy were divided into 2 groups:one for developing the model(n=110) and one for validation(n=80). Histological staging of liver fibrosis,assessed blindly and independently by 2 pathologists,was determined according to Scheuer fibrosis score.Twenty markers involved in the study were analyzed initially in the estimation group to derive a predictive model to discriminate the stages of fibrosis.The model created was then assessed with receiver operating characteristic curve(ROC)analysis. It was also applied to the validation group to test its accuracy. Results Haptoglobin(HPT),γ-glutamyl transpeptidase(GGT)and platelet were identified by logistic regression analysis as independent factors of fibrosis. A model developed from the above three markers was established to predict the stage of fibrosis(S). In ROC analysis,the area under curve(AUC) for identifying S≥1,S≥2,S≥3 and S=4 was 0.832,0.835,0.820 and 0.843 respectively. The model had a similar AUC in the vatidation group without statistically significant difierence. Using a cut-off of <0.18, significant fibrosis (S≥2)could be excluded in 27 patients of the total patient population(negative predictive value 90%).Similarly,applying a cut-off ≥0.70,significant fibrosis could be identified correctly in 67 patients of the total patient population(positive predictive value 82.7%).The model had a high level of diagnostic value in patients with HBeAg-positive chronic hepatitis B as well as in patients with HBeAg-negative chronic hepatitis B(AUC for identifying S≥2,0.857 vs 0.802). Restricting biopsy to patients with intermediate scores(≥0.70 and <0.18) may prevent liver biopsies in 58.4% of the patients while maintaining 84.7% accuracy. Conclusions A model including HPT,GGT and platelet is a simple and reliable index for predicting significant fibrosis in patients with HBeAg-positive chronic hepatitis B as well as in patients with HBeAg-negative chronic hepatitis B.
Citation statistics
Recommended Citation
GB/T 7714
刘卫平,许德军,赵连荣,等. 慢性乙型肝炎肝纤维化无创检测模型建立及应用价值验证[J]. 中华内科杂志,2008,47(4):308-312.
APA 刘卫平.,许德军.,赵连荣.,陆忠华.,王玉华.,...&王贵强.(2008).慢性乙型肝炎肝纤维化无创检测模型建立及应用价值验证.中华内科杂志,47(4),308-312.
MLA 刘卫平,et al."慢性乙型肝炎肝纤维化无创检测模型建立及应用价值验证".中华内科杂志 47.4(2008):308-312.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Usage statistics
Export to Endnote
谷歌学术Similar articles in
[刘卫平]'s Articles
[许德军]'s Articles
[赵连荣]'s Articles
百度学术Similar articles in
[刘卫平]'s Articles
[许德军]'s Articles
[赵连荣]'s Articles
必应学术Similar articles in
[刘卫平]'s Articles
[许德军]'s Articles
[赵连荣]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.